[1]LI CZ,HU WW,LI W,et al.Effect of time of biliary drainage on biliary obstructive liver fibrosis in rats[J].J Clin Hepatol,2011,27(9):944-946.(in Chinese)李长政,胡文炜,李闻,等.胆汁引流时机对大鼠胆管阻塞性肝纤维化的影响[J].临床肝胆病杂志,2011,27(9):944-946.
|
[2]SCHMITT J,RODERFELD M,SABRANE K,et al.Complement factor C5 deficiency significantly delays the progression of biliary fibrosis in bile duct-ligated mice[J].Biochem Biophys Res Commun,2012,418(3):445-450.
|
[3]LI CZ,GUO SL.LI QS,et al.Polymorphism of complement C5gene and susceptibility to liver cirrhosis in patients with chronic hepatitis B[J].J Pract Hepatol,2011,14(6):427-429.(in Chinese)李长政,郭水龙,李青山,等.补体C5a基因多态性与肝硬化发病关系的研究[J].实用肝脏病杂志,2011,14(6):427-429.
|
[4]RODRIGUEZ-OSORIO L,ORTIZ A.Timing of eculizumab therapy for C3 glomerulonephritis[J].Clin Kidney J,2015,8(4):449-452.
|
[5]MERLE NS,NOE R,HALBWACHS-MECARELLI L,et al.Complement system partⅡ:role in immunity[J].Front Immunol,2015,6:257.
|
[6]WONG GL.Prediction of fibrosis progression in chronic viral hepatitis[J].Clin Mol Hepatol,2014,20(3):228-236.
|
[7]ZHOU Y,XIONG HP,CHEN Q,et al.Relationship between serum markers and severity of liver fibrosis in patients with chronic hepatitis D[J].J Clin Hepatol,2015,31(3):361-364.(in Chinese)周颖,熊红品,陈铿,等.血清肝纤维化标志物与慢性丁型肝炎肝纤维化程度关系的探讨[J].临床肝胆病杂志,2015,31(3):361-364.
|
[8]DAS D,BARNES MA,NAGY LE.Anaphylatoxin C5a modulates hepatic stellate cell migration[J].Fibrogenesis Tissue Repair,2014,7:9.
|
[9]GU H,MICKLER EA,CUMMINGS OW,et al.Crosstalk between TGF-β1 and complement activation augments epithelial injury in pulmonary fibrosis[J].FASEB J,2014,28(10):4223-4234.
|
[10]DANOBEITIA JS,DJAMALI A,FERNANDEZ LA.The role of complement in the pathogenesis of renal ischemia-reperfusion injury and fibrosis[J].Fibrogenesis Tissue Repair,2014,7:16.
|
[11]XU GL,CHEN J,YANG F,et al.C5a/C5aR pathway is essential for the pathogenesis of murine viral fulminant hepatitis by way of potentiating Fgl2/fibroleukin expression[J].Hepatology,2014,60(1):114-124.
|
[1] | Xiaoyong DUO, Shijie ZHANG, Hongwei ZHANG, Jing YANG, Wenqiang WANG, Linzhi YU, Baocai ZHANG, Yicheng ZHUO, Yunchao JIA, Yan PENG, Shuai HU. Association between gallstones and metabolic syndrome in southern Xinjiang, China[J]. Journal of Clinical Hepatology, 2022, 38(8): 1859-1864. doi: 10.3969/j.issn.1001-5256.2022.08.026 |
[2] | Aipire ALIYEGULI, Maimaitiyusufu PIERDIWASI, Jian WANG, Aili AIKEBAIER, Abudureyimu KELIMU. Effects of FGB gene polymorphism on fibrinogen level and gallstones incidence in Xinjiang, China[J]. Journal of Clinical Hepatology, 2021, 37(9): 2171-2176. doi: 10.3969/j.issn.1001-5256.2021.09.032 |
[3] | Peng Lu:Cheng, Shao ZhangFeng, Chen JiaQin, Chen Wei. Effect of aerobic exercise combined with silybin on intestinal mucosal barrier in mice with obstructive jaundice[J]. Journal of Clinical Hepatology, 2020, 36(7): 1577-1583. doi: 10.3969/j.issn.1001-5256.2020.07.025 |
[4] | Li ChangXu, Yuan JingJing, Wang ShouQian, Xu LuYao, Wang YingChao. Perioperative coagulation factor Ⅷ replacement therapy for patients with gallbladder stones and hemophilia A: A report of three cases[J]. Journal of Clinical Hepatology, 2020, 36(9): 2075-2076. doi: 10.3969/j.issn.1001-5256.2020.09.036 |
[5] | Zhu PeiYao, Yang Jun, Yang Yong, Han YaDong, Zhuang Lei, Han Yong. Necessity of magnetic resonance cholangiopancreatography in patients with initial diagnosis of gallstones on color Doppler ultrasound and an analysis of related indications[J]. Journal of Clinical Hepatology, 2019, 35(6): 1293-1298. doi: 10.3969/j.issn.1001-5256.2019.06.022 |
[6] | Hong Cen, Han JuQiang, Qi XingShun. An excerpt of AGA clinical practice update: Coagulation in cirrhosis (2019)[J]. Journal of Clinical Hepatology, 2019, 35(10): 2191-2191. doi: 10.3969/j.issn.1001-5256.2019.10.011 |
[7] | Xiong Zhuang, Liu YangYang, Huo ShaoKai, Gong JiaLian, Jin TianYi, Wang Qiang, Wang HuiLin, Liu TieJun, Leng Yan. Research advances in vitamin K1 in treatment of coagulopathy of liver failure[J]. Journal of Clinical Hepatology, 2019, 35(9): 2099-2103. doi: 10.3969/j.issn.1001-5256.2019.09.048 |
[8] | Li HongHong, Zhao Ge, Xue JunJun, Ning YaWen, Guo HongYi, Li WenLong, Guo ChunLei. A case of double gallbladder malformation with obstructive jaundice[J]. Journal of Clinical Hepatology, 2018, 34(7): 1535-1537. doi: 10.3969/j.issn.1001-5256.2018.07.036 |
[9] | Wang XianPeng, Meng XianZhi. Risk factors for gallstones complicated by acute biliary pancreatitis[J]. Journal of Clinical Hepatology, 2018, 34(8): 1728-1732. doi: 10.3969/j.issn.1001-5256.2018.08.027 |
[10] | Wang Bin, Luo Xiao, Sun BaoZhen, Yang Guang, Meng ZiHui, Ji DeGang. Laparoscopic cholecystectomy for cold agglutinin syndrome with gallstones: a case report[J]. Journal of Clinical Hepatology, 2017, 33(4): 740-741. doi: 10.3969/j.issn.1001-5256.2017.04.032 |
[11] | Wang Qiang, Zhang XianYong, Yan XiaoLin. Association of blood lipid levels with the risk of cholecystectomy and postoperative pain[J]. Journal of Clinical Hepatology, 2017, 33(10): 1961-1965. doi: 10.3969/j.issn.1001-5256.2017.10.022 |
[12] | Zhou BingBing, Wang XueMei, Zhang Qian, Xu ShiYi, Dan ZhongYan, Lai YaXin, Wang HaoYu. Association between metabolic syndrome and gallstones[J]. Journal of Clinical Hepatology, 2017, 33(5): 880-882. doi: 10.3969/j.issn.1001-5256.2017.05.017 |
[13] | Li Jing, Wu GuangLi, Wang Wei, Xiao Xin, Liu HuiNa, Qu DongDong, Cai YiWei. Analysis of pathogenic bacteria in bile and blood of patients with obstructive jaundice[J]. Journal of Clinical Hepatology, 2017, 33(2): 320-323. doi: 10.3969/j.issn.1001-5256.2017.02.025 |
[14] | Li Juan, Wei XiaoGuo, Lu QiMing, Zhan Li, Liu PengCheng. Research advances in association between diseases outside the gallbladder and gallstones[J]. Journal of Clinical Hepatology, 2016, 32(5): 1018-1021. doi: 10.3969/j.issn.1001-5256.2016.05.050 |
[15] | Li ZhangZheng, Liu QuanDa, Yu HuiJie, Hu WenWei, Li Xue, Liu MingHao. Correlation between serum levels of complement C5a and liver fibrosis markers in patients with obstructive jaundice[J]. Journal of Clinical Hepatology, 2016, 32(3): 495-498. doi: 10.3969/j.issn.1001-5256.2016.03.020 |
[16] | Pan YaJun, Sun ShaoFu. Predictive value of serum CA19-9 in predicting acute cholangitis in patients with obstructive jaundice[J]. Journal of Clinical Hepatology, 2016, 32(8): 1553-1556. doi: 10.3969/j.issn.1001-5256.2016.08.024 |
[17] | Lin QianHuang, Xu Hui, Tang XiaoLong, Ding Zheng, Tang WenJun, Wu KaiKai, Xun JinLiang. A case of gallstones with gallbladder-stomach fistula and biliary ileus[J]. Journal of Clinical Hepatology, 2016, 32(11): 2177-2178. doi: 10.3969/j.issn.1001-5256.2016.11.039 |
[18] | Dai ShuLong, Yang ShiYong, Yang KunXing. Systemic sclerosis with gallbladder stone disease: a report of one case[J]. Journal of Clinical Hepatology, 2015, 31(6): 963-964. doi: 10.3969/j.issn.1001-5256.2015.06.033 |
[19] | Zhang Peng, Yu CongHui. Clinical analysis of relationship between gallstone morphology and biliary pancreatitis[J]. Journal of Clinical Hepatology, 2014, 30(1): 46-49. doi: 10.3969/j.issn.1001-5256.2014.01.015 |
[20] | Wang TianRan, Wang LanTian, Qu YuanQing, Gu Yu, Zou ZiYing, Chen Li. Comparative analysis of serum markers of cardiac function in a rabbit model of and human patients with obstructive jaundice [J]. Journal of Clinical Hepatology, 2013, 29(3): 227-229. |